MYC oncogenes and human neoplastic disease

Chadd Nesbit, Jean M. Tersak, Edward V. Prochownik

Research output: Contribution to journalReview article

858 Citations (Scopus)

Abstract

c-myc, N-myc and L-myc are the three members of the myc oncoprotein family whose role in the pathogenesis of many human neoplastic diseases has received wide empirical support. In this review, we first summarize data, derived mainly from non-clinical studies, indicating that these oncoproteins actually serve quite different roles in vivo. This concept necessarily lies at the heart of the basis for the observation that the deregulated expression of each MYC gene is reproducibly associated with only certain naturally occurring malignancies in humans and that these genes are not interchangeable with respect to their aberrant functional consequences. We also review evidence implicating each of the above MYC genes in specific neoplastic diseases and have attempted to identify unresolved questions which deserve further basic or clinical investigation. We have made every attempt to review those diseases for which significant and confirmatory evidence, based on studies with primary tumor material, exists to implicate MYC members in their causation and/or progression.

Original languageEnglish (US)
Pages (from-to)3004-3016
Number of pages13
JournalOncogene
Volume18
Issue number19
DOIs
StatePublished - May 13 1999

Fingerprint

Oncogenes
Oncogene Proteins
Genes
Causality
Neoplasms

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Nesbit, C., Tersak, J. M., & Prochownik, E. V. (1999). MYC oncogenes and human neoplastic disease. Oncogene, 18(19), 3004-3016. https://doi.org/10.1038/sj.onc.1202746
Nesbit, Chadd ; Tersak, Jean M. ; Prochownik, Edward V. / MYC oncogenes and human neoplastic disease. In: Oncogene. 1999 ; Vol. 18, No. 19. pp. 3004-3016.
@article{dfe4b514291e431a93c304c01a7ab9ed,
title = "MYC oncogenes and human neoplastic disease",
abstract = "c-myc, N-myc and L-myc are the three members of the myc oncoprotein family whose role in the pathogenesis of many human neoplastic diseases has received wide empirical support. In this review, we first summarize data, derived mainly from non-clinical studies, indicating that these oncoproteins actually serve quite different roles in vivo. This concept necessarily lies at the heart of the basis for the observation that the deregulated expression of each MYC gene is reproducibly associated with only certain naturally occurring malignancies in humans and that these genes are not interchangeable with respect to their aberrant functional consequences. We also review evidence implicating each of the above MYC genes in specific neoplastic diseases and have attempted to identify unresolved questions which deserve further basic or clinical investigation. We have made every attempt to review those diseases for which significant and confirmatory evidence, based on studies with primary tumor material, exists to implicate MYC members in their causation and/or progression.",
author = "Chadd Nesbit and Tersak, {Jean M.} and Prochownik, {Edward V.}",
year = "1999",
month = "5",
day = "13",
doi = "10.1038/sj.onc.1202746",
language = "English (US)",
volume = "18",
pages = "3004--3016",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "19",

}

Nesbit, C, Tersak, JM & Prochownik, EV 1999, 'MYC oncogenes and human neoplastic disease', Oncogene, vol. 18, no. 19, pp. 3004-3016. https://doi.org/10.1038/sj.onc.1202746

MYC oncogenes and human neoplastic disease. / Nesbit, Chadd; Tersak, Jean M.; Prochownik, Edward V.

In: Oncogene, Vol. 18, No. 19, 13.05.1999, p. 3004-3016.

Research output: Contribution to journalReview article

TY - JOUR

T1 - MYC oncogenes and human neoplastic disease

AU - Nesbit, Chadd

AU - Tersak, Jean M.

AU - Prochownik, Edward V.

PY - 1999/5/13

Y1 - 1999/5/13

N2 - c-myc, N-myc and L-myc are the three members of the myc oncoprotein family whose role in the pathogenesis of many human neoplastic diseases has received wide empirical support. In this review, we first summarize data, derived mainly from non-clinical studies, indicating that these oncoproteins actually serve quite different roles in vivo. This concept necessarily lies at the heart of the basis for the observation that the deregulated expression of each MYC gene is reproducibly associated with only certain naturally occurring malignancies in humans and that these genes are not interchangeable with respect to their aberrant functional consequences. We also review evidence implicating each of the above MYC genes in specific neoplastic diseases and have attempted to identify unresolved questions which deserve further basic or clinical investigation. We have made every attempt to review those diseases for which significant and confirmatory evidence, based on studies with primary tumor material, exists to implicate MYC members in their causation and/or progression.

AB - c-myc, N-myc and L-myc are the three members of the myc oncoprotein family whose role in the pathogenesis of many human neoplastic diseases has received wide empirical support. In this review, we first summarize data, derived mainly from non-clinical studies, indicating that these oncoproteins actually serve quite different roles in vivo. This concept necessarily lies at the heart of the basis for the observation that the deregulated expression of each MYC gene is reproducibly associated with only certain naturally occurring malignancies in humans and that these genes are not interchangeable with respect to their aberrant functional consequences. We also review evidence implicating each of the above MYC genes in specific neoplastic diseases and have attempted to identify unresolved questions which deserve further basic or clinical investigation. We have made every attempt to review those diseases for which significant and confirmatory evidence, based on studies with primary tumor material, exists to implicate MYC members in their causation and/or progression.

UR - http://www.scopus.com/inward/record.url?scp=0033551374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033551374&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202746

DO - 10.1038/sj.onc.1202746

M3 - Review article

VL - 18

SP - 3004

EP - 3016

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 19

ER -